Univest
Univest
  • Markets
  • 3 Specialty Branded Generics, Global Generics and Injectables and Cardiac Therapy Leader Stocks With a Strong Future Roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals

    • October 23, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Specialty Branded Generics, Global Generics and Injectables and Cardiac Therapy Leader Stocks With a Strong Future Roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals

    Branded Generic and Global Formulation Stocks with a strong future roadmap: Ajanta Pharma, Aurobindo Pharma and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more
  • 3 Domestic Brand Pharma, Global Generics Leader and Injectables Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Lupin and Aurobindo Pharma

    • October 22, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Domestic Brand Pharma, Global Generics Leader and Injectables Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Lupin and Aurobindo Pharma

    Large Pharma and Domestic Brand Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Lupin and Aurobindo Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Sterile Injectables, Finished Dosages and Integrated Generics Stocks With a Strong Future Roadmap: Gland Pharma, Granules India and Aurobindo Pharma

    • October 22, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Sterile Injectables, Finished Dosages and Integrated Generics Stocks With a Strong Future Roadmap: Gland Pharma, Granules India and Aurobindo Pharma

    Generic Drug Manufacturing Stocks with a strong future roadmap: Gland Pharma, Granules India and Aurobindo Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Global Generics, Branded Generics and Contract Formulations Stocks With a Strong Future Roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab

    • October 21, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Global Generics, Branded Generics and Contract Formulations Stocks With a Strong Future Roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab

    Generic and Branded Pharma Stocks with a strong future roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 3 Global Generics Major, Farm Chemical Maker and Household Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer Products

    • October 19, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Global Generics Major, Farm Chemical Maker and Household Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer Products

    Aurobindo Pharma, Deepak Fertilisers and Godrej Consumer Products compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Formulation Major, Infusion Set Maker and Pizza Chain Stocks With a Strong Future Roadmap: Aurobindo Pharma, Poly Medicure and Jubilant FoodWorks

    • October 19, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Formulation Major, Infusion Set Maker and Pizza Chain Stocks With a Strong Future Roadmap: Aurobindo Pharma, Poly Medicure and Jubilant FoodWorks

    Aurobindo Pharma, Poly Medicure and Jubilant FoodWorks compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 US-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, India Glycols and Heritage Foods

    • October 19, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 US-Focused Drug Maker, Ethanol Chemical Firm and Milk Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, India Glycols and Heritage Foods

    Aurobindo Pharma, India Glycols and Heritage Foods compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Generic Drug Major, Surfactant and Footwear Stocks With a Strong Future Roadmap: Aurobindo Pharma, Galaxy Surfactants and Redtape

    • October 19, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Generic Drug Major, Surfactant and Footwear Stocks With a Strong Future Roadmap: Aurobindo Pharma, Galaxy Surfactants and Redtape

    Aurobindo Pharma, Galaxy Surfactants and Redtape compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Formulation Exporter, Borax Producer and Diversified FMCG Group Stocks With a Strong Future Roadmap: Aurobindo Pharma, Indo Borax & Chemicals and ITC

    • October 19, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Formulation Exporter, Borax Producer and Diversified FMCG Group Stocks With a Strong Future Roadmap: Aurobindo Pharma, Indo Borax & Chemicals and ITC

    Aurobindo Pharma, Indo Borax & Chemicals and ITC compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Formulations and API Major, Surface Treatment Chemical and Fortune Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Grauer & Weil (India) and AWL Agri Business

    • October 16, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Formulations and API Major, Surface Treatment Chemical and Fortune Brand Stocks With a Strong Future Roadmap: Aurobindo Pharma, Grauer & Weil (India) and AWL Agri Business

    Aurobindo Pharma, Grauer & Weil (India) and AWL Agri Business compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 1
  • 2